Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Treasury Shares (2021 - 2025)

Silo Pharma (SILO) has disclosed Treasury Shares for 5 consecutive years, with $10.2 million as the latest value for Q4 2025.

  • Quarterly Treasury Shares rose 362.98% to $10.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.2 million through Dec 2025, up 362.98% year-over-year, with the annual reading at $10.2 million for FY2025, 362.98% up from the prior year.
  • Treasury Shares hit $6268.0 in Q3 2024 for Silo Pharma, down from $644234.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $17.4 million in Q1 2022 to a low of $1559.0 in Q3 2023.
  • Historically, Treasury Shares has averaged $4.1 million across 5 years, with a median of $404580.0 in 2022.
  • Biggest YoY gain for Treasury Shares was 3876.51% in 2024; the steepest drop was 96.13% in 2024.
  • Year by year, Treasury Shares stood at $471121.0 in 2023, then tumbled by 98.67% to $6268.0 in 2024.
  • Business Quant data shows Treasury Shares for SILO at $10.2 million in Q4 2025, $7.2 million in Q3 2025, and $8.3 million in Q2 2025.